Prayer #384: For the FDA-Recommended Pause in Administering the Johnson and Johnson COVID-19 Vaccine
The Food and Drug Administration (FDA) announced today that it is recommending a pause in administering the Johnson and Johnson one-dose vaccine for COVID-19. The reason for this recommendation is the fact that there have been six identified cases in the United States of a rare and severe type of blood clot in individuals, ages 18 to 48, after receiving the J&J vaccine. Thus far, 6.8 million doses of the vaccine have been administered in the U.S. The clots in the six cases developed within two weeks of receiving the vaccine and were observed along with reduced platelet counts, which made the use of heparin, the normal treatment for the blood clots, potentially dangerous. Though this adverse reaction to the vaccine "appears to be extremely rare," according to the FDA statement, nevertheless the agency is recommending that the use of the vaccine be paused pending further study. "We are recommending a pause in the use of this vaccine out of an abundance of caution," the FDA said. "Treatment of this specific type of blood clot is different from the treatment that might typically be administered." At this point, nearly 7 million people have received the Johnson and Johnson vaccine in this country, and an additional 9 million doses have been shipped to various states. The other two vaccines in use, manufactured by Pfizer and Moderna, are not affected by the FDA-recommended pause. The Johnson and Johnson vaccine accounts for about 5% of the overall vaccination in the U.S.
Pray for those who are tasked now to study this vaccine, particularly the Centers for Disease Control's Advisory Committee on Immunization Practices as well as the FDA itself. Pray also for vaccination centers across the United States as they respond to the FDA's strong recommendation.
Ps. 59:9 "O my Strength, I will sing praises to Thee; for Thou, O God, art my fortress."